Functional intracellular P-glycoprotein

International Journal of Cancer

Volumn 76, Issue 6, 1998, Pages 857-864

  Shapiro, Adam B ^a   Fox, Kelly ^a   Lee, Pat ^a   Yang, Yvonne D ^a   Ling, Victor ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; GLYCOPROTEIN P; HOE 33342;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CELLULAR DISTRIBUTION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0032503555     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19980610)76:6<857::aid-ijc15>3.0.co;2-%23     Document Type: Article

References (37)

1. ABBASZADEGAN, M.R., CRESS, A.E., FUTSCHER, B.W., BELLAMY, W.T., and DALTON, W.S., Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers. Cancer Res., 56, 5435-5442 (1996).
2. ARCECI, R.J., Clinical significance of P-glyeoprotein in multidrug resistant malignancies. Blood, 81, 2215-2222 (1993).
3. BAR-SAGI, D. and FERAMISCO, J.R., Induction of membrane ruffling and fluid-phase pinocytosis in quiescent tihroblasts by ras proteins. Science, 233, 1061-1068 (1986).
4. BECH-HANSEN, N.J., TILL, J.E., and LING, V., Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity, J. Cell. Physiol., 88, 23-31 (1976).
5. BECK, W.T., The cell biology of multiple drug resistance. Biochem. Pharmacol., 36, 2879-2887 (1987).
6. CHAUFFERT, B., MARTIN, F., CAIGNARD, A., JEANNIN, J.-F., and LECLERC, A., Cytofluorescience localization of adriamycin in resistant colon cancer cells. Cancer Chemother. Pharmacol., 13, 14-18 (1984).
7. CHEN, A.Y., YU, C., BODLEY, A., PFNG, L.F. and LIU, L.F., A new mammalian DNA topoisomerase I poison Hoechst 33342: cytotoxicity and drug resistance in human cell cultures Cancer Res., 53, 1332-1337 (1993).
8. COLE, S.P.C., BHARDWAJ, G., GERLACH, J.H., MACKIE, J.E., GRANT, C.E., ALMQUIST, K.C., STEWART, A.J., KURZ, E.U., DUNCAN, A.M.V., and DEELEY, R.G., Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654 (1992).
9. COLE, S.P.C., CHANDA, E.R., DICKE, F.P., GERLACH, J.H., and MIRSKI, S.E.L., Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topisomerase II. Cancer Res., 51, 3345-3352 (1991).
10. COLEY, H.M., AMOS, W.B., TWENTYMAN, P.R., and WORKMAN, P., Examination by laser scanning con focal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines. Brit. J. Cancer, 67, 1316-1323 (1993).
11. FAWCETT, D.W., The cell (2nd ed.), pp. 96-107, W.B. Saunders, Toronto (1981).
12. FRANCIS, C.L., RYAN, T.A., JONES, B.D., SMITH, J., and FALKOW, S., Ruffles induced by Salmonella and other stimuli direct micropinocytosis of bacteria. Nature (Lond.), 364, 639-642 (1993).
13. GERVASONI, J.E. Jr., FIELDS, S.Z., KRISHNA, S., BAKER, M.A., ROSADO, M., THURAISAMY, K., HINDENBURG, A.A., and TAUB, R.N., Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res., 51, 4955-4963 (1991).
14. GOTTESMAN, M.M. and PASTAN, I., Biochemistry of multidrug resistance mediated by the multidrug transporter Ann. Rev. Biochem., 62, 385-427 (1993).
15. HARRIGAN, P.R., WONG, K.F., REDELMEIER, T.E., WHEELER, J.J., and CULLIS, P.R., Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradients. Biochim. biophys. Acta. 1149, 329-338 (1993).
16. JULIANO, R.L. and LING, V., A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. biophys. Acta, 455, 152-162 (1976).
17. LALANDE, M.E., LING, V., and MILLER, R.G., Hoechst 33342 dye uptake as a probe of membrane permeability changes in mammalian cells. Proc. nat. Acad. Sci. (Wash.), 78, 363-367 (1981).
18. LING, V. and THOMPSON, L.H., Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J. cell. Physiol., 83, 103-116 (1974).
19. MARTIN, S.R., Absorption and circular dichroic spectral studies on the self-association of daunorubicin. Biopolymers, 19, 713-721 (1980).
20. MECHETNER, E.B. and RONINSON, I.B., Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc. nat. Acad. Sci. (Wash.), 89, 5824-5828 (1992).
21. MICKISCH, G.H., PAI, L.H., GOTTESMAN, M.M., and PASTAN, I., Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug resistant transgenic mice. Cancer Res., 52, 4427-4432 (1992).
22. NIELSEN, D. and SKOVSGAARD, T., P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines. Biochim. biophys. Acta, 1139, 169-183 (1992).
23. i by beef heart mitochondrial adenosine triphosphatase. J. Biol. Chem., 252, 2891-2897 (1977).
24. RIORDAN, J.R., DEUCHARS, K., KARTNER, N., ALON, N., TRENT, J., and LING, V., Amplification of P-glycoprotein genes in multidrug resistant mammalian cell lines. Nature, 316, 817-819 (1985).
25. RITTMAN-GRAUER, L.S., YONG, M.A., SANDERS. V., and MACKENSEN, D. G., Reversal of Vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft. Cancer Res., 52, 1810-1816 (1992).
26. ROEPE, P.D., Analysis of the steady-state and initial rates of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein. Biochemistry, 31, 12555-12564 (1992).
27. SCHUURHUIS, G.J., VAN HEIJNINGEN, T.H.M., CERVANTES, A., PINEDO, H. M., DE LANGE, J.H.M., KEIZER, H.G., BROXTERMAN, H.J., BAAK, J.P.A., and LANKELMA, J., Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account tor doxorubicin resistance in SW-1573 king cancer and MCF-7 breast cancer multidrug resistant tumour cells. Brit. J. Cancer, 68, 898-908 (1993).
28. SHAPIRO, A.B. and LING, V., Using purified P-glycoprotein to understand multidrug resistance. J. Bioenerg. Biomembr., 27, 7-13 (1995a).
29. SHAPIRO, A.B. and LING, V., Reconstitution of drug transport by purified P-glycoproiein J. biol. Chem., 270, 16167-16175 (1995b).
30. SLAPAK, C.A., MIZUNUMA, N., and KUFE, D.W., Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells. Blood, 84, 3113-3121 (1994).
31. SMITH, P.J., SYKES, H.R., Fox, M.E., and FURLONG, I.J., Subcellular distribution of the anticancer drug mitoxamrone in human and drug-resistant murine cells analyzed by flow cytometry and confocal microscopy and its relationship to the induction of DNA damage. Cancer Res., 52, 4000-4008 (1992).
32. SOGNIER, M.A., ZHANG, Y., EBERLE, R.L., SWEET, K.M., ALTENBERG, G.A., and BELLI, J.A., Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100). Biochem. Pharmacol., 48, 391-401 (1994).
33. VEROVSKI, V.N., VAN DEN BERGE, D.L., DELVAEYE, M.M., SCHEPER, R.J., DE NEVE, W.J., and STORME, G.A., Low-level doxorubicin resistance in P-glycoprotein-negative human pancreatic tumour PSN1/ADR cells implicates a brefeldin A-sensitive mechanism of drug extrusion. Brit. J. Cancer, 73, 596-602 (1996).
34. WlLLINGHAM, M.C., CORNWELL, M.M., CARDARRLLI, C.O., GOTTESMAN, M.M., and PASTAN, I., Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs. Cancer Res., 46, 5941-5946 (1986).
35. WILLINGHAM, M.C. and PASTAN, I., An atlas of immunofluorescence in cultured cells, pp. 18-21, 52-59, Academic Press, Toronto (1985).
36. WILLINGHAM, M.C., RICHERT, N.D., CORNWELL, M.M., TSURUO, T., HAMADA, H., GOTTESMAN, M.M., and PASTAN, I., Immunocytochemical localization of P170 at the plasma membrane of multidrug resistant human cells. J. Histochem. Cytochem., 35, 1451-1456 (1987).
37. ZAMAN, G.J.R., FLENS, M.J., VAN LEUSDEN, M.R., DE HAAS, M., MÜLDER, H.S., LANKELMA, J., PINEDO, H.M., SCHEPER, R.J., BAAS, F., BROXTERMAN, H.J., and BORST, P., The human multidrug resistance associated protein MRP is a plasma membrane drug-efflux pump. Proc. nat. Acad. Sci. (Wash.), 91, 8822-8826 (1994).